Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables

Background: Continuous glucose monitoring (CGM) remains underutilized in youth with type 1 diabetes (T1D). There is a need to investigate factors associated with CGM use. Method: In 61 T1D youth, CGM use was ascertained by downloads reflecting the 4-week periods preceding 3- and 6-month study visits...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes science and technology 2017-05, Vol.11 (3), p.476-483
Main Authors: Giani, Elisa, Snelgrove, Rebecca, Volkening, Lisa K., Laffel, Lori M.
Format: Article
Language:English
Subjects:
Adolescent
Child
Diabetes Mellitus, Type 1
Female
Glucose - analysis
Humans
Male
Monitoring, Physiologic - methods
Monitoring, Physiologic - psychology
Patient Compliance - psychology
Psychology
Special Section: Adherence and Diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Continuous glucose monitoring (CGM) remains underutilized in youth with type 1 diabetes (T1D). There is a need to investigate factors associated with CGM use. Method: In 61 T1D youth, CGM use was ascertained by downloads reflecting the 4-week periods preceding 3- and 6-month study visits. Demographic and clinical data were obtained from chart review and interview. Youth and parents completed validated psychosocial surveys at baseline and 6 months. Results: Youth (52% male, 93% Caucasian, 80% pump treated) were 12.7 ± 2.9 years old, with T1D for 6.3 ± 3.8 years; mean A1c was 7.9 ± 0.9%. Mean CGM use was 4.1 ± 2.1 days/week (median = 4.8) at 3 months and 3.4 ± 2.3 days/week (median = 3.9) at 6 months. At 3 and 6 months, 15% and 20% of youth, respectively, had stopped using CGM. At 6 months, youth using CGM 6-7 days/week had more frequent BG monitoring (P = .05), less insulin omission (P = .02), and greater probability of A1c < 7.5% (P = .01) than youth using CGM less often. Youth using CGM 6-7 days/week consistently over the 6 months demonstrated lower A1c at 3 months compared to baseline (P = .03) and the improvement was sustained at 6 months (P = .5, 3 vs 6 months); youth using CGM less often had no significant A1c change. Baseline BG monitoring ≥8 times/day or A1c within target (
ISSN:1932-2968
1932-2968
1932-3107
DOI:10.1177/1932296816676280